FDA Brief

Warning letters Food

FDA warning letter to

Comercializadora Internacional Piscicola New Your S.A

High riskIssued Jan 8, 2024Posted Jan 16, 2024Center for Food Safety and Applied Nutrition

Colombian tilapia processor's HACCP plan omits Clostridium botulinum and drug-residue hazards, FDA says after remote assessment.

What happened

FDA carried out a Foreign Remote Regulatory Assessment (an off-site review of the plant's records and procedures) of the firm's seafood processing facility in Colombia from May 23 through May 29, 2023. At the end, the investigator gave the firm a list of the deviations found, and FDA says it has received no response. FDA found the firm's HACCP plan for fresh and frozen whole or filleted tilapia does not list Clostridium botulinum as a hazard at one processing step, the individual packages carry no "keep frozen" statement, and the plan does not address aquaculture drug or environmental contaminant hazards from receiving live fish.

What FDA found

  1. The HACCP plan for tilapia does not list Clostridium botulinum, a bacterium that can grow in fish and produce a deadly toxin, as a food safety hazard at one of the processing steps.

    21 CFR 123.6(a) and (c)(1)
  2. The individual packages have no label statement telling users to keep the product frozen.

    21 CFR 123.6(a) and (c)(1)
  3. The firm takes in live tilapia from farms that may use aquaculture drugs, but the HACCP plan does not identify aquaculture drug residues or environmental contaminants as hazards at receiving.

    21 CFR 123.6(a) and (c)(1)
  4. Because these requirements were not met, FDA deems the fish adulterated, meaning it was prepared, packed or held under conditions where it may have been made harmful to health.

    21 U.S.C. ยง 342(a)(4) (Section 402(a)(4) of the Act); 21 CFR 123.6(g)
  5. The firm did not respond to the observations FDA left at the end of the assessment.

What FDA wants

FDA asks the firm to reply in writing within 15 working days outlining the corrections, with a revised HACCP plan and five consecutive days of completed monitoring records covering five production date codes. If all corrections cannot be finished in that time, the firm must explain the delay and say when the rest will be done.

Who should pay attention

  • U.S. importers and distributors of Colombian tilapia
  • brands and retailers buying frozen tilapia fillets from Latin American processors
  • food safety teams at seafood buyers who rely on supplier HACCP plans

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  2. Star Ocean Wholesale Foods, Inc.

    FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.

    High risk
  3. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  4. AF Import & Wholesale Co

    FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.

    High risk